Comparing the Roles of Omalizumab and Ultraviolet Therapy in Treating Severe Pediatric Atopic Dermatitis
JAMA Pediatr
.
2021 Feb 1;175(2):205.
doi: 10.1001/jamapediatrics.2020.0960.
Author
Jewel Park
1
Affiliation
1
Korea University College of Medicine, Seoul, Korea.
PMID:
32539105
DOI:
10.1001/jamapediatrics.2020.0960
No abstract available
Publication types
Comment
MeSH terms
Anti-Allergic Agents* / therapeutic use
Child
Dermatitis, Atopic* / drug therapy
Humans
Omalizumab / therapeutic use
Ultraviolet Therapy*
Substances
Anti-Allergic Agents
Omalizumab